Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in alzheimer's disease

Correlations were sought between local cerebral metabolic rates (LCMRs) for glucose in various regions of the cortex, determined in premortem PET scans, with the regional activities of choline acetyltransferase (ChAT), acetylcholinesterase (AChE), β‐glucuronidase (Gluc, a probable index of reactive gliosis), and phosphate‐activated glutaminase (PAG, a possible indice of the large pyramidal neurons) measured on postmortem tissue. Significant negative correlations between LCMRs and Gluc activities were found in 6 PET‐scanned cases of Alzheimer disease (AD), and positive correlations of LCMRs with PAG were found in 5. By contrast, a positive correlation with ChAT and AChE was found in only 1. The results are consistent with the metabolic deficits in AD being primarily a reflection of local neuronal loss and gliosis. Similar data on two cases of Huntington's disease showed no significant correlations, while 1 patient with Parkinson dementia showed a significant (negative) correlation only with Gluc.

[1]  P. Mcgeer,et al.  Cortical Glutaminase, β-Glucuronidase and Glucose Utilization in Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[2]  Patrick L. McGeer,et al.  Molecular Neurobiology of the Mammalian Brain , 1978, Springer US.

[3]  J. Edwardson,et al.  Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases , 1988, Journal of the Neurological Sciences.

[4]  J. Donoghue,et al.  Localization of glutaminase-like and aspartate aminotransferase-like immunoreactivity in neurons of cerebral neocortex , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  M. Piercey,et al.  Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces , 1987, Brain Research.

[6]  H. Arai,et al.  Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia , 1984, Neuroscience Letters.

[7]  James V. Haxby,et al.  Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  M. Beal,et al.  Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in alzheimer's disease , 1988, Annals of neurology.

[9]  P. Mcgeer,et al.  Crossed cerebellar and uncrossed basal ganglia and thalarnic diaschisis in Alzheimer's disease , 1989, Neurology.

[10]  G. Reynolds,et al.  Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases , 1985, Journal of the Neurological Sciences.

[11]  E. London,et al.  Effects of oxotremorine on local glucose utilization in the rat cerebral cortex , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  S. Tyrrell.  NO CHILDHOOD , 1975, The Lancet.

[13]  J. Baron,et al.  Cortical Hypometabolism and its Recovery following Nucleus Basalis Lesions in Baboons: A PET Study , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  D. Pleasure,et al.  Astrocyte Metabolism of [15N]Glutamine: Implications for the Glutamine‐Glutamate Cycle , 1988, Journal of neurochemistry.

[15]  B. L. Beattie,et al.  18Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  B. Berger,et al.  Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type , 1989, Brain Research.

[17]  H. Soininen,et al.  Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease , 1987, Brain Research.

[18]  D. Bowen,et al.  Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism. , 1988, The Biochemical journal.

[19]  A. Cross,et al.  Subcellular Pathology of Human Neurodegenerative Disorders: Alzheimer‐Type Dementia and Huntington's Disease , 1986, Journal of neurochemistry.

[20]  F. Orzi,et al.  Local cerebral glucose utilization following unilateral and bilateral lesions of the nucleus basalis magnocellularis in the rat , 1988, Brain Research.

[21]  P. Mcgeer,et al.  Brain imaging in Alzheimer's disease. , 1986, British medical bulletin.

[22]  R Harrop,et al.  Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease , 1986, Neurology.

[23]  I. Mackenzie,et al.  Reactivity to Epidermal Langerhans Cells to a Histochemical Method for Demonstration of β-Glucuronidase , 1982 .

[24]  N. Foster,et al.  Alzheimer's disease , 1987, Neurology.

[25]  Stanley I. Rapoport,et al.  Arecoline-induced elevations of regional cerebral metabolism in the conscious rat , 1985, Brain Research.

[26]  S. Vincent,et al.  Somatostatin- and Neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of alzheimer's type , 1986, Brain Research.

[27]  M. Esiri,et al.  Topographical distribution of neurochemical changes in Alzheimer's disease , 1988, Journal of the Neurological Sciences.

[28]  N. Sims,et al.  [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex. , 1981, The Biochemical journal.

[29]  C. Cotman,et al.  Immunocytochemical localization of glutaminase-like and aspartate aminotransferase-like immunoreactivities in the rat and guinea pig hippocampus , 1985, Brain Research.

[30]  H. Fibiger,et al.  Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis , 1984, Brain Research.

[31]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[33]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  J. Morrison,et al.  Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  R. Robbins.  Influence of Glucose on Somatostatin Synthesis and Secretion in Isolated Cerebral Cortical Cells , 1983, Journal of neurochemistry.

[36]  W. Schöpp,et al.  Histochemically demonstrable activity of phosphate-activated glutaminase in the postnatally developing rat hippocampus. , 1988, Brain research.